These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33028644)

  • 1. Infantile fibrosarcoma-like tumor driven by novel
    Gupta A; Belsky JA; Schieffer KM; Leraas K; Varga E; McGrath SD; Koo SC; Magrini V; Wilson RK; White P; Mardis ER; Jatana KR; Cottrell CE; Setty BA
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
    Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
    J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.
    Nagasubramanian R; Wei J; Gordon P; Rastatter JC; Cox MC; Pappo A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1468-70. PubMed ID: 27093299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second Report of
    Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
    Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
    Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
    J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile NTRK-associated Mesenchymal Tumors.
    Davis JL; Lockwood CM; Albert CM; Tsuchiya K; Hawkins DS; Rudzinski ER
    Pediatr Dev Pathol; 2018; 21(1):68-78. PubMed ID: 28683589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum.
    van Spronsen R; Kester LA; Knops RRG; van de Sande MAJ; van Leenders GJLH; de Laat PCJ; Stortelder E; Korpershoek E; van Noesel MM; Meister MT; Koerkamp MJAG; de Graaf N; Giovannoni I; Tops BBJ; de Krijger RR; Ter Horst SAJ; Flucke U; Alaggio R; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2022 Apr; 57():151885. PubMed ID: 35032896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
    Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH
    Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34/S100 protein-positive, NTRK1-rearranged infantile fibrosarcoma-like tumors in genitourinary system: two cases expanding the clinicopathologic spectrum and illustrating the diagnostic dilemma.
    Zhao M; Xu J; Wang J
    Virchows Arch; 2024 Sep; 485(3):575-581. PubMed ID: 38801436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory and metastatic infantile fibrosarcoma harboring
    Bender J; Anderson B; Bloom DA; Rabah R; McDougall R; Vats P; Mody R
    Cold Spring Harb Mol Case Stud; 2019 Feb; 5(1):. PubMed ID: 30709876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With
    Hanf D; Heining C; Laaber K; Nebelung H; Uhrig S; Hutter B; Jahn A; Richter D; Aust D; Herbst F; Fröhling S; Glimm H; Folprecht G
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250401
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
    Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
    Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H
    Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
    Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ETV6-NTRK3 gene fusion in primary renal fibrosarcoma.
    Jiang H
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.